New study to reveal if modern melanoma drugs harm fertility
Knowledge-focused
Recruiting now
This study follows 270 women under 40 who have had melanoma removed and are now taking adjuvant therapies like dabrafenib, trametinib, pembrolizumab, or nivolumab. Researchers will measure ovarian reserve using a blood test before and after treatment to see how these drugs affect…
Sponsor: Intergruppo Melanoma Italiano • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:53 UTC